Ann K. Donohue
Keine laufenden Positionen mehr
Profil
Ann K.
Donohue served as the VP, Chief Financial & Accounting Officer at Selecta Biosciences, Inc. in 2021.
She received her undergraduate and graduate degrees from the Wallace E Carroll School of Management.
Ehemalige bekannte Positionen von Ann K. Donohue
| Unternehmen | Position | Ende |
|---|---|---|
| CARTESIAN THERAPEUTICS, INC. | Director of Finance/CFO | 20.09.2021 |
Ausbildung von Ann K. Donohue
| Wallace E Carroll School of Management | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Selecta Biosciences, Inc.
 Selecta Biosciences, Inc. BiotechnologyHealth Technology Selecta Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. Its portfolio includes pipeline, autoimmune, gene therapy, and biologic therapy. The company was founded by Omid C. Farokhzad, Robert S. Langer Jr., and Ulrich von Andrian on December 10, 2007 and is headquartered in Watertown, MA. | Health Technology |
